Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724731 | SCV000227672 | uncertain significance | not provided | 2017-06-13 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000223116 | SCV000271655 | uncertain significance | not specified | 2015-04-28 | criteria provided, single submitter | clinical testing | The p.Thr847Ala variant in DMD has not been previously reported in individuals w ith cardiomyopathy, but has been identified in 4/8508 African chromosomes, inclu ding one male, by the Exome Aggregation Consortium (ExAC, http://exac.broadinsti tute.org; dbSNP rs138145424). Computational prediction tools and conservation an alysis suggest that this variant may not impact the protein, though this informa tion is not predictive enough to rule out pathogenicity. In summary, the clinica l significance of the p.Thr847Ala variant is uncertain. |
Gene |
RCV000724731 | SCV000619814 | benign | not provided | 2020-06-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620846 | SCV000737010 | likely benign | Cardiovascular phenotype | 2020-03-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000685504 | SCV000812987 | benign | Duchenne muscular dystrophy | 2023-12-12 | criteria provided, single submitter | clinical testing |